Presence of SARS-CoV-2 antibodies following COVID-19 diagnosis: a longitudinal study of patients at a major urgent care provider in New York
Authors:
- 4 May 2022
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 103 (4) , 115720
Abstract
No abstract availableKeywords
Funding Information
- City University of New York
This publication has 25 references indexed in Scilit:
- COVID-19 Outbreak — New York City, February 29–June 1, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Serological follow-up of SARS-CoV-2 asymptomatic subjectsScientific Reports, 2020
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsScience Immunology, 2020
- Naturally activated adaptive immunity in COVID‐19 patientsJournal of Cellular and Molecular Medicine, 2020
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severityNature Communications, 2020
- Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 InfectionsThe Journal of Infectious Diseases, 2020
- COVID-19, SARS and MERS: are they closely related?Clinical Microbiology and Infection, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Demographic Determinants of Testing Incidence and COVID-19 Infections in New York City Neighborhoods2020